Electroconvulsive Therapy News and Research

RSS

Electroconvulsive therapy (ECT) involves the induction of a seizure for therapeutic purposes by the administration of a variable frequency electrical stimulus shock via electrodes applied to the scalp.

Single-dose psilocybin shows promise for treatment-resistant depression in NHS trial

A single 25-mg dose of psilocybin with psychological support was feasible to deliver within an NHS setting and produced large preliminary reductions in depressive symptoms among adults with treatment-resistant depression. The Phase 2 feasibility trial also found the treatment was generally well tolerated, although functional unblinding and expectancy effects mean larger, longer efficacy studies are needed.

10 Aug 2026

ECT-like brain stimulation triggers unexpected nuclear reprogramming in mature neurons

Nearly 90 years after Ugo Cerletti and Lucio Bini introduced electroconvulsive therapy (ECT), brain stimulation therapies such as ECT and Repetitive Transcranial Magnetic Stimulation (rTMS) are common in psychiatry because they are highly effective for treating depression and schizophrenia, yet their cellular mechanisms remain poorly understood

17 Jul 2026

Deep brain stimulation rewires brain circuits linked to depression

Researchers from the Icahn School of Medicine at Mount Sinai have uncovered the first direct evidence that deep brain stimulation (DBS) can remodel white matter pathways in the brain and alter communication across large-scale neural networks, revealing a previously unrecognized mechanism that may explain how the therapy helps patients recover from severe depression.

1 Jun 2026

Retinal stimulation via contact lenses effective as antidepressants in mice

Materials scientists have designed brain-stimulating contact lenses that are as effective as Prozac at treating depression in mice. The soft, transparent contact lenses have in-built electrodes that deliver mild electrical signals to the brain via the retina to stimulate specific brain regions associated with depression.

14 May 2026

Survey of families suggests high risks for electroconvulsive therapy

Electroconvulsive therapy (ECT), which involves passing electricity through the brain under general anesthesia to cause a seizure, usually between six and twelve times, is used to varying degrees around the world for patients with depression and other mental conditions.

22 Apr 2026

Researchers prove magnetic seizures are comparable to ECT in clinical response

A landmark international clinical trial led by researchers at the Centre for Addiction and Mental Health (CAMH) and University of California San Diego School of Medicine, published in The Lancet Psychiatry, has found that magnetic seizure therapy (MST) is as effective as electroconvulsive therapy (ECT)-the current gold-standard treatment for severe, treatment-resistant depression-with significantly fewer cognitive side effects. The study is the first large-scale, randomized clinical trial to directly compare MST with ECT, marking an important step toward a new treatment option for patients.

16 Apr 2026

Implanted vagus nerve stimulation device offers lasting relief for severe depression

About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few treatment attempts, but up to one-third of patients have treatment-resistant depression, for which standard antidepressant medication or psychotherapy isn't enough.

13 Jan 2026

Electroconvulsive therapy found to be highly effective in treating elderly patients with depression

Electroconvulsive therapy is a safe and effective treatment for elderly patients suffering from depression.

25 Nov 2025

The caffeine conundrum in rapid depression treatments

Perhaps the most intriguing implication of recent breakthrough research lies in an unexpected connection: the most rigorous mechanistic dissection of rapid antidepressant action identifies adenosine as the critical mediator, yet adenosine receptors are the primary target of caffeine, the world's most widely consumed psychoactive substance.

11 Nov 2025

Can creatine help with depression? New review says results are inconclusive

Creatine supplementation may modestly reduce depressive symptoms, but the effect is small, uncertain, and likely influenced by study bias. The evidence remains of very low quality, highlighting the need for larger, well-designed clinical trials.

6 Nov 2025

Patients recall inadequate disclosure of electroconvulsive therapy risks

The medical pros of electroconvulsive therapy (ECT) are being exaggerated while the risks are being downplayed, suggest the findings of a survey on the type of information patients and their relatives/friends recall having been given before the procedure, and published online in the Journal of Medical Ethics.

17 Aug 2025

New brain network discovery could revolutionize depression diagnosis

In a comprehensive Genomic Press Commentary published today, researchers have identified what could be the first reliable biomarker for depression risk, potentially transforming how this devastating condition is identified and treated.

13 May 2025

Electrophysiological markers for personalizing transcranial magnetic stimulation in depression

Not all patients with depression respond to medication. Two recently published studies provide additional information on how an alternative treatment, transcranial magnetic stimulation (TMS), could be further enhanced.

24 Jun 2024

Novel head-mounted device shows promise in alleviating depression symptoms

A head-mounted device that generates an ultra-low frequency ultralow magnetic field has been found to improve the symptoms of four male patients diagnosed with major depressive disorder.

8 May 2024

Electroconvulsive Therapy found to be safe and effective treatment for some mental illnesses

Researchers have found that Electroconvulsive Therapy (ECT), where an electric current is passed through the brain, can reduce the severity of mental illnesses.

9 Apr 2024

New treatments in sight for challenging neuropsychiatric symptoms in neurodegenerative diseases

Study reviews the advancements in pharmacological treatments for neuropsychiatric syndromes in neurodegenerative disorders, discussing the complexities of managing symptoms such as depression, disinhibition, apathy, psychosis, and agitation to improve patient care.

3 Apr 2024

Electroconvulsive Therapy News and Research

Further Reading

Single-dose psilocybin shows promise for treatment-resistant depression in NHS trial

ECT-like brain stimulation triggers unexpected nuclear reprogramming in mature neurons

Deep brain stimulation rewires brain circuits linked to depression

Retinal stimulation via contact lenses effective as antidepressants in mice

Survey of families suggests high risks for electroconvulsive therapy

Researchers prove magnetic seizures are comparable to ECT in clinical response

Implanted vagus nerve stimulation device offers lasting relief for severe depression

Electroconvulsive therapy found to be highly effective in treating elderly patients with depression

The caffeine conundrum in rapid depression treatments

Can creatine help with depression? New review says results are inconclusive

Patients recall inadequate disclosure of electroconvulsive therapy risks

New brain network discovery could revolutionize depression diagnosis

Electrophysiological markers for personalizing transcranial magnetic stimulation in depression

Novel head-mounted device shows promise in alleviating depression symptoms

Electroconvulsive Therapy found to be safe and effective treatment for some mental illnesses

New treatments in sight for challenging neuropsychiatric symptoms in neurodegenerative diseases

A new $16,000 postpartum depression drug is here. How will insurers handle it?

She once advised the president on aging issues. Now, she’s battling serious disability and depression.

Electroconvulsive therapy alleviates depression symptoms by increasing aperiodic activity

New evidence-based clinical practice guidelines to address peripartum depression

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News